[1] 司壮丽,周远忠. 耐药结核病发生和传播的分子流行病学研究进展[J]. 牡丹江医学院学报, 2015, 36(5):92-96.
SI Z L, ZHOU Y Z. Advances in molecular epidemiology of the occurrence and transmission of drug-resistant tuberculosis[J]. Journal of Mudanjiang Medical University, 2015, 36(5):92-96. (in Chinese)
[2] World Health Organization. Global tuberculosis report[R]. Global Tuberculosis Report. France:WHO, 2017.
[3] VARIAVA E, MARTINSON N. Drug-resistant tuberculosis:the rise of the monos[J]. Lancet Infect Dis, 2018, 18(7):705-706.
[4] OFENGEIM D, YUAN J Y. Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death[J]. Nat Rev Mol Cell Biol, 2013, 14(11):727-736.
[5] XU Q, JITKAEW S, CHOKSI S, et al. The cytoplasmic nuclear receptor RARγ controls RIP1 initiated cell death when cIAP activity is inhibited[J]. Nat Commun, 2017, 8(1):425.
[6] ROCA F J, RAMAKRISHNAN L. TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species[J]. Cell, 2013, 153(3):521-534.
[7] XU Y, JAGANNATH C, LIU X D, et al. Toll-like receptor 4 is a sensor for autophagy associated with innate immunity[J]. Immunity, 2007, 27(1):135-144.
[8] BERTRAND M J M, MILUTINOVIC S, DICKSON K M, et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination[J]. Mol Cell, 2008, 30(6):689-700.
[9] CHEN C, XIAO W, HUANG L, et al. Shikonin induces apoptosis and necroptosis in pancreatic cancer via regulating the expression of RIP1/RIP3 and synergizes the activity of gemcitabine[J]. Am J Transl Res, 2017, 9(12):5507-5517.
[10] LUAN Q, JIN L, JIANG C C, et al. RIPK1 regulates survival of human melanoma cells upon endoplasmic reticulum stress through autophagy[J]. Autophagy, 2015, 11(7):975-994.
[11] FESTJENS N, VANDEN BERGHE T, CORNELIS S, et al. RIP1, a kinase on the crossroads of a cell's decision to live or die[J]. Cell Death Differ, 2007, 14(3):400-410.
[12] 张嘉美,马臣杰,赵宁,等. Necrostatin-1对BCG感染后小鼠巨噬细胞RAW264. 7凋亡的调控[J]. 农业生物技术学报, 2016, 24(10):1552-1559.
ZHANG J M,MA C J, ZHAO N, et al. Necrostatin-1 modulate the apoptosis induced by BCG in a macrophage cell line RAW264. 7[J]. Journal of Agricultural Biotechnology, 2016, 24(10):1552-1559. (in Chinese)
[13] ASHKENAZI A, FAIRBROTHER W J, LEVERSON J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nat Rev Drug Discov, 2017, 16(4):273-284.
[14] ROOS W P, THOMAS A D, KAINA B. DNA damage and the balance between survival and death in cancer biology[J]. Nat Rev Cancer, 2016, 16(1):20-33.
[15] COLSTON M J. The molecular basis of mycobacterial infection[J]. Mol Aspects Med, 1996, 17(4):385-454.
[16] AWUH J A, FLO T H. Molecular basis of mycobacterial survival in macrophages[J]. Cell Mol Life Sci, 2017, 74(9):1625-1648.
[17] BEHAR S M, MARTIN C J, BOOTY M G, et al. Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis[J]. Mucosal Immunol, 2011, 4(3):279-287.
[18] WU X L, DENG G C, HAO X J, et al. A caspase-dependent pathway is involved in Wnt/β-catenin signaling promoted apoptosis in bacillus calmette-guerin infected RAW264. 7 macrophages[J]. Int J Mol Sci, 2014, 15(3):5045-5062.
[19] HOLLER N, ZARU R, MICHEAU O, et al. Fas triggers an alternative, caspase-8-independent cell death pathway usingthe kinase RIP as effector molecule[J]. Nat Immunol, 2000, 1(6):489-495.
[20] ZWERLING A, BEHR M A, VERMA A, et al. The BCG World Atlas:a database of global BCG vaccination policies and practices[J]. PLoS Med, 2011, 8(3):e1001012.
[21] ORME I M. The Achilles heel of BCG[J]. Tuberculosis (Edinb), 2010, 90(6):329-332.
[22] WINAU F, WEBER S, SAD S, et al. Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis[J]. Immunity, 2006, 24(1):105-117.
[23] FARINACCI M, WEBER S, KAUFMANN S H E. The recombinant tuberculosis vaccine rBCG ΔureC::hly+ induces apoptotic vesicles for improved priming of CD4+ and CD8+ T cells[J]. Vaccine, 2012, 30(52):7608-7614.
[24] CRISTOFANON S, ABHARI B A, KRUEGER M, et al. Identification of RIP1 as a critical mediator of Smac mimetic-mediated sensitization of glioblastoma cells for Drozitumab-induced apoptosis[J]. Cell Death Dis, 2015, 6:e1724.
[25] WANG J S, WU D, HUANG D Y, et al. TAK1 inhibition-induced RIP1-dependent apoptosis in murine macrophages relies on constitutive TNF-α signaling and ROS production[J]. J Biomed Sci, 2015, 22(1):76.
[26] DONDELINGER Y, AGUILETA M A, GOOSSENS V, et al. RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition[J]. Cell Death Differ, 2013, 20(10):1381-1392.
[27] FAYNGERTS S A, WANG Z J, ZAMANI A, et al. Direction of leukocyte polarization and migration by the phosphoinositide-transfer protein TIPE2[J]. Nat Immunol, 2017, 18(12):1353-1360.
[28] MIHALY S R, NINOMIYA-TSUJI J, MORIOKA S. TAK1 control of cell death[J]. Cell Death Differ, 2014, 21(11):1667-1676.
[29] YU X F, PAN Y H, MA H S, et al. Simvastatin inhibits proliferation and induces apoptosis in human lung cancer cells[J]. Oncol Res, 2013, 20(8):351-357.
[30] DÍAZ-GARCÍA A, MORIER-DÍAZ L, FRIÓN-HERRERA Y, et al. In vitro anticancer effect of venom from Cuban scorpion Rhopalurus junceus against a panel of human cancer cell lines[J]. J Venom Res, 2013, 4:5-12.
[31] PARK S, RAMNARAIN D B, HATANPAA K J, et al. The death domain-containing kinase RIP1 regulates p27Kip1 levels through the PI3K-Akt-forkhead pathway[J]. EMBO Rep, 2008, 9(8):766-773. |